XPACE-2003
Pipeline Category
Pharmaceutical
Short Description / Indication
XPACE-2003 is a preclinical-stage prophylactic mRNA vaccine candidate being developed by Xanadu Bio to target human influenza
Areas of Focus
Infectious disease
Licensees
| Company Name | Company Website URL |
|---|---|
| Xanadu Bio | https://xanadubio.com/ |
Pharmaceutical Status